BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 10772417)

  • 21. Are there several types of colorectal carcinomas? Correlations with genetic data.
    Martin L; Assem M; Piard F
    Eur J Cancer Prev; 1999 Dec; 8 Suppl 1():S13-20. PubMed ID: 10772413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multistep carcinogenesis in colorectal cancers.
    Takami K; Yana I; Kurahashi H; Nishisho I
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():190-6. PubMed ID: 8629105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No difference in the occurrence of mismatch repair defects and APC and CTNNB1 genes mutation in a multi-racial colorectal carcinoma patient cohort.
    Tan LP; Ng BK; Balraj P; Lim PK; Peh SC
    Pathology; 2007 Apr; 39(2):228-34. PubMed ID: 17454753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
    Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A
    J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer.
    Chiang JM; Chou YH; Chou TB
    Cancer Res; 1998 Aug; 58(15):3289-93. PubMed ID: 9699657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis.
    Yagishita H; Yoshida T; Ishiguro K; Numata Y; Okayasu I
    Scand J Gastroenterol; 2008; 43(5):559-66. PubMed ID: 18415748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
    Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions.
    Halford S; Rowan A; Sawyer E; Talbot I; Tomlinson I
    Gut; 2005 Jun; 54(6):797-802. PubMed ID: 15888787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
    Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.
    Smith G; Carey FA; Beattie J; Wilkie MJ; Lightfoot TJ; Coxhead J; Garner RC; Steele RJ; Wolf CR
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9433-8. PubMed ID: 12093899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
    Kim H; Yang XL; Rosada C; Hamilton SR; August JT
    Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.
    Abraham SC; Park SJ; Lee JH; Mugartegui L; Wu TT
    Mod Pathol; 2003 Aug; 16(8):786-95. PubMed ID: 12920223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
    Baker K; Raut P; Jass JR
    J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Colorectal oncogenesis].
    Laurent-Puig P; Agostini J; Maley K
    Bull Cancer; 2010 Nov; 97(11):1311-21. PubMed ID: 21115420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
    Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
    Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers.
    Simms LA; Radford-Smith G; Biden KG; Buttenshaw R; Cummings M; Jass JR; Young J; Meltzer SJ; Leggett BA
    Oncogene; 1998 Oct; 17(15):2003-8. PubMed ID: 9788444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of colorectal polyps.
    Molatore S; Ranzani GN
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s240-2. PubMed ID: 15666098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsatellite alterations and target gene mutations in the early stages of multiple gastric cancer.
    Ogata S; Tamura G; Endoh Y; Sakata K; Ohmura K; Motoyama T
    J Pathol; 2001 Jul; 194(3):334-40. PubMed ID: 11439366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular biology of colorectal cancer.
    Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
    Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.